The Latest Breakthroughs in LG-IR-NMIBC (2025)
AUAUniversity26 Sep 2025

The Latest Breakthroughs in LG-IR-NMIBC (2025)

The Latest Breakthroughs in LG-IR-NMIBC (2025) CME Available: auau.auanet.org/node/43689 After participating in this CME activity, participants will be able to: 1. Apply updated clinical evidence and treatment protocols for low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC) in appropriate patient cases to reduce recurrence rates and improve clinical outcomes. 2. Improve clinical decision-making related to risk stratification and surveillance strategies for low-grade, intermediate-risk NMIBC based on pathophysiology, epidemiology, and progression patterns. 3. Support evidence-based, patient-centered treatment selection options for low-grade, intermediate-risk NMIBC by comparing traditional intravesical therapies with emerging treatments. 4. Interpret the efficacy and safety profiles of new therapies to appropriately integrate new therapeutic options into clinical practice (upon regulatory approval). 5. Utilize new medications in the evolving treatment landscape following an evaluation of key clinical trial data from recent studies. 6. Assess the impact of treatment options on patient-reported outcomes, including quality of life and treatment burden, to guide shared decision-making and optimize care delivery. ACKNOWLEDGEMENTS Support provided by an independent educational grant from: UroGen Pharma, Inc.

Episoder(426)

Update Series 2025: Congenitalism: Transitioning Patients with Congenital Urological Anomalies

Update Series 2025: Congenitalism: Transitioning Patients with Congenital Urological Anomalies

Update Series 2025 Lesson 9: Congenitalism: Transitioning Patients with Congenital Urological Anomalies from the Pediatric to the Adult Care Setting Update Series 2025 Lesson 9: Congenitalism: Transi...

9 Apr 202525min

AUA2025: Masterclass: Renal Access and Interventions (2025)

AUA2025: Masterclass: Renal Access and Interventions (2025)

AUA2025: Masterclass: Renal Access and Interventions (2025) Cohost: Rob Sweet, MD, FACS, MAMSE and Thomas Chi, MD, MBA Tune in to hear straight from the experts about what you can expect from our NE...

19 Mar 202530min

Hereditary Kidney Cancer Syndromes (Republished)

Hereditary Kidney Cancer Syndromes (Republished)

Hereditary Kidney Cancer Syndromes CME Available: https://auau.auanet.org/node/41772 ACKNOWLEDGEMENTS: Support provided by an independent educational grant from:  Merck & Co., Inc.  LEARNING OBJECT...

11 Mar 202538min

AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)

AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025)

AUA2025: Fundamentals of Prostate MRI and Transperineal Interventions (2025) Cohost: Arvin K. George, MD and James Wysock, MD, MSc Tune in to hear straight from the experts about what you can expect...

3 Mar 202536min

Recognition and Management of Complications Following Gender Affirming Surgery

Recognition and Management of Complications Following Gender Affirming Surgery

Recognition and Management of Complications Following Gender Affirming Surgery Co-Host: Laura Douglass, MD Outline: Segment #1 Topic: Why is this important for ALL urologists to know? Segment #2 T...

25 Feb 202541min

AUA Guidelines: Diagnosis and Treatment of Infertility in Men

AUA Guidelines: Diagnosis and Treatment of Infertility in Men

AUA Guidelines: Diagnosis and Treatment of Infertility in Men Co-Host: Robert E. Brannigan, MD Outline: Segment #1 Topic: New Table 1 Reviewing “Common Terms” in Semen Analysis and Update to the WHO...

19 Feb 202538min

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder

AUA Guidelines: Diagnosis And Treatment Of Idiopathic Overactive Bladder Co-Host: Anne Pelletier Cameron, MD, FRCSC, URPS Segment #1: Is this an update to the prior Guideline? Segment #2: What is n...

12 Feb 202542min

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer

AUA Guidelines: Treatment Of Non - Metastatic Muscle - Invasive Bladder Cancer Guest: Jeffrey M Holzbeierlein, MD Outline: Segment #1: Guideline Statement 9-Patients who have not received cisplatin-...

5 Feb 202535min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
treningspodden
rss-strid-de-norske-borgerkrigene
foreldreradet
rss-sunn-okonomi
jakt-og-fiskepodden
takk-og-lov-med-anine-kierulf
sinnsyn
merry-quizmas
rss-kunsten-a-leve
lederskap-nhhs-podkast-om-ledelse
smart-forklart
hverdagspsyken
gravid-uke-for-uke
level-up-med-anniken-binz
hagespiren-podcast
rss-kull
fryktlos